EP.12H.02 Amivantamab, An EGFR-MET Bispecific Antibody, with Cetrelimab, An Anti-PD-1 Antibody, In Advanced NSCLC: Phase 1/2 Polydamas
P.J. Voon(Sarawak General Hospital), Ju Le Tan(University of Malaya), A.I. Spira(Virginia Cancer Specialists), B. Keam(Seoul National University Hospital), S.-H. Lee(Samsung Medical Center), Bing Xia(Janssen (Belgium)), Eunice Artis(Janssen (United States)), Jessica Dobbs(Janssen (United States)), Christine Baudelet(Janssen (Belgium)), Mirza Rafi Baig(Janssen (United States)), J.M. Bauml(Springhouse), Mehmet Alı Nahıt Şendur(Ankara Yıldırım Beyazıt University), B.C. Cho(Yonsei University)
Cited by 1Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis